Effects of Ventilation With Tidal Volume Adjusted on Driving Pressure on Ventilation/Perfusion Ratios and Hemodynamics in ARDS
Hemodriving
1 other identifier
observational
20
1 country
1
Brief Summary
The driving pressure (DP) is defined as the pressure above the end-expiratory pressure (PEEP) required to distend the respiratory system by the tidal volume (Vt). It is calculated as follows: DP = Plateau pressure - PEEP. It is also equal to the ratio between the tidal volume and the compliance of the respiratory system (Crs): DP = Vt/Crs. Crs is correlated with end-expiratory lung volume, i.e., the lung volume available to receive the tidal volume. DP allows adaptation of the Vt to the available lung volume when the lungs are diseased, rather than to a fraction of lung size when they are healthy, as occurs when tidal volume is adjusted in mL/kg of predicted body weight (PBW). DP is therefore a better reflection of the deformation applied by the tidal volume and the risk of overdistension. It is an important prognostic indicator in acute respiratory distress syndrome (ARDS), with a risk of excess mortality when DP exceeds 14 cm H2O. Conversely, an excessively low DP, suggesting a low tidal volume in relation to the available lung volume, may theoretically also be accompanied by deleterious effects: de-recruitment, atelectrauma, the need to increase respiratory rate, the need for significant sedation, or even curarization. DP and Vt can influence hemodynamics, as overdistension is associated with an increase in dead space and the occurrence of acute cor pulmonale. On the other hand, de-recruitment due to low tidal volume can lead to hypoxic vasoconstriction with an increase in right ventricular afterload.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2025
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedStudy Start
First participant enrolled
March 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 5, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 2, 2027
February 10, 2025
February 1, 2025
2 years
January 7, 2025
February 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
distribution of perfusion and ventilation across VA/Q ratios zones, wasted ventilation and perfusion.
demonstration that ventilate patient with ARDS with an objective of protective driving pressure vent may change VA/Q ratio by using electrical impedance tomography
24 hours
Secondary Outcomes (2)
DP-vent may induce a modification in patient with right ventricular
24 hours
Change in right ventricular systolic function parameters
24 hours
Interventions
To ventilated patients with ARDS with an objective of driving pressure than a tidal volume set on predicted body weight
Eligibility Criteria
All patients with ARDS under deep sedation +/- paralized
You may qualify if:
- Age ≥ 18 years
- ARDS moderate to severe according to the Berlin criteria
- Patient receiving continuous sedation and curarization
- Free and informed consent from the patient or family member
You may not qualify if:
- Pregnancy
- Adult patient subject to a legal protection measure (tutor, curator, etc.)
- Patients with a pacemaker, automatic implantable cardioverter defibrillator,
- Contraindications to thoracic belt placement (e.g., thoracic or spinal cord trauma, recent thoracic surgery)
- Undrained pneumothorax, bronchopleural fistula
- Hemodynamic instability (i.e., use of intravenous fluids of more than 10 mL/kg or vasopressors 2 mg/h of norepinephrine or 0.5 mg/h of epinephrine)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR
Créteil, 94010, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2025
First Posted
February 10, 2025
Study Start
March 3, 2025
Primary Completion (Estimated)
March 5, 2027
Study Completion (Estimated)
April 2, 2027
Last Updated
February 10, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
DATAS ARE OWN BY ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS, PLEASE CONTACT SPONSOR FOR FURTHER INFORMATION